Nosantine racemate (NPT-15392 racemate) is primarily explored for its immunomodulatory properties. It is being studied for its potential to enhance immune responses, particularly in the context of cancer immunotherapy. Researchers are investigating its ability to stimulate the activity of natural killer (NK) cells and T-cells, which are crucial for targeting and destroying cancer cells. Additionally, it is being evaluated for its role in improving the efficacy of vaccines by boosting the immune system's ability to recognize and respond to pathogens. Its application extends to autoimmune diseases, where it may help regulate overactive immune responses. Ongoing preclinical and clinical trials aim to further define its therapeutic potential in these areas.